Cheng-Wen Lin,Casey Kopczynski,Mitchell A. deLong,Jill M. Sturdivant,Ramesh Krishnamoorthy
申请号：
US15691607
公开号：
US20180055833A1
申请日:
2017.08.30
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present disclosure provides an ophthalmic composition comprising 4-(3-amino-1-(isoquinolin-6-ylamino)-1-oxopropan-2-yl)benzyl 2,4-dimethylbenzoate or its pharmaceutically acceptable salts about 0.01% weight/volume to about 1.0% weight/volume of a buffer and about 0.01% weight/volume to about 10% weight/volume of a tonicity agent.
